The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation V De Stefano, I Martinelli, PM Mannucci, K Paciaroni, P Chiusolo, ... New England Journal of Medicine 341 (11), 801-806, 1999 | 700 | 1999 |
Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism J Emmerich, FR Rosendaal, M Cattaneo, M Margaglione, V De Stefano, ... Thrombosis and haemostasis 86 (09), 809-816, 2001 | 552 | 2001 |
Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients V De Stefano, P Chiusolo, K Paciaroni, I Casorelli, E Rossi, M Molinari, ... Blood, The Journal of the American Society of Hematology 91 (10), 3562-3565, 1998 | 367 | 1998 |
Preponderance of methylenetetrahydrofolate reductase C677T homozygosity among leukemia patients intolerant to methotrexate P Chiusolo, G Reddiconto, I Casorelli, L Laurenti, F Sora, L Mele, ... Annals of oncology 13 (12), 1915-1918, 2002 | 209 | 2002 |
Thermolabile methylenetetrahydrofolate reductase and factor V Leiden in the risk of deep-vein thrombosis LAJ Kluijtmans, M Den Heijer, PH Reitsma, SG Heil, HJ Blom, ... Thrombosis and haemostasis 79 (02), 254-258, 1998 | 207 | 1998 |
Interaction between hyperhomocysteinemia, mutated methylenetetrahydrofolatereductase (MTHFR) and inherited thrombophilic factors in recurrent venous thrombosis MBAJ KeiJzer, M Den Heijer, HJ Blom, GMJ Bos, HPJ Willems, ... Thrombosis and haemostasis 88 (11), 723-728, 2002 | 135 | 2002 |
The risk of recurrent venous thromboembolism among heterozygous carriers of the G20210A prothrombin gene mutation V De Stefano, I Martinelli, PM Mannucci, K Paciaroni, E Rossi, P Chiusolo, ... British journal of haematology 113 (3), 630-635, 2001 | 128 | 2001 |
The HR2 haplotype of factor V: effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis MCH de Visser, JF Guasch, PW Kamphuisen, HL Vos, FR Rosendaal, ... Thrombosis and haemostasis 83 (04), 577-582, 2000 | 123 | 2000 |
Hyperhomocysteinemia and prevalence of polymorphisms of homocysteine metabolism-related enzymes in patients with inflammatory bowel disease A Papa, V De Stefano, S Danese, P Chiusolo, S Persichilli, I Casorelli, ... Official journal of the American College of Gastroenterology| ACG 96 (9 …, 2001 | 119 | 2001 |
Mismatch repair and response to DNA-damaging antitumour therapies M Bignami, I Casorelli, P Karran European journal of cancer 39 (15), 2142-2149, 2003 | 117 | 2003 |
Interaction between hyperhomocysteinemia and inherited thrombophilic factors in venous thromboembolism V DE STEFANO, IDA Casorelli, E Rossi, B Zappacosta, G Leone Seminars in thrombosis and hemostasis 26 (03), 305-312, 2000 | 103 | 2000 |
Prevalence of mild hyperhomocysteinaemia and association with thrombophilic genotypes (factor V Leiden and prothrombin G20210A) in Italian patients with venous thromboembolic … V De Stefano, B Zappacosta, S Persichilli, E Rossi, I Casorelli, ... British journal of haematology 106 (2), 564-568, 1999 | 85 | 1999 |
Role of mismatch repair and MGMT in response to anticancer therapies I Casorelli, MT Russo, M Bignami Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2008 | 82 | 2008 |
The VITA project: prothrombin G20210A mutation and venous thromboembolism in the general population A Tosetto, E Missiaglia, M Frezzato, F Rodeghiero Thrombosis and haemostasis 82 (11), 1395-1398, 1999 | 76 | 1999 |
Drug treatment in the development of mismatch repair defective acute leukemia and myelodysplastic syndrome I Casorelli, J Offman, L Mele, L Pagano, S Sica, M D’Errico, G Giannini, ... DNA repair 2 (5), 547-559, 2003 | 70 | 2003 |
DNA damage and repair in human cancer: molecular mechanisms and contribution to therapy-related leukemias I Casorelli, C Bossa, M Bignami International journal of environmental research and public health 9 (8 …, 2012 | 61 | 2012 |
Increased prevalence of the G20210A prothrombin gene variant in acute coronary syndromes without metabolic or acquired risk factors or with limited extent of disease F Burzotta, K Paciaroni, V De Stefano, P Chiusolo, A Manzoli, I Casorelli, ... European Heart Journal 23 (1), 26-30, 2002 | 61 | 2002 |
Role of MUTYH and MSH2 in the control of oxidative DNA damage, genetic instability, and tumorigenesis MT Russo, G De Luca, I Casorelli, P Degan, S Molatore, F Barone, ... Cancer research 69 (10), 4372-4379, 2009 | 59 | 2009 |
The C807T/G873A polymorphism in the platelet glycoprotein Ia gene and the risk of acute coronary syndrome in the Italian population I Casorelli, V De Stefano, AM Leone, P Chiusolo, F Burzotta, K Paciaroni, ... British journal of haematology 114 (1), 150-154, 2001 | 50 | 2001 |
Prevalence of factor V Leiden and the G20210A prothrombin-gene mutation in inflammatory bowel disease A Papa, V De Stefano, A Gasbarrini, P Chiusolo, R Cianci, I Casorelli, ... Blood coagulation & fibrinolysis 11 (5), 499-503, 2000 | 49 | 2000 |